These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 23559272

  • 21. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
    Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H.
    Cancer Lett; 2012 Mar 28; 316(2):196-203. PubMed ID: 22169097
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Four serum microRNAs identified as diagnostic biomarkers of sepsis.
    Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX.
    J Trauma Acute Care Surg; 2012 Oct 28; 73(4):850-4. PubMed ID: 23026916
    [Abstract] [Full Text] [Related]

  • 24. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 28; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

  • 25. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D.
    Mol Carcinog; 2011 Feb 28; 50(2):136-42. PubMed ID: 21229610
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.
    Cancer Genomics Proteomics; 2013 Feb 28; 10(3):93-113. PubMed ID: 23741026
    [Abstract] [Full Text] [Related]

  • 27. Identification of serum microRNAs as diagnostic and prognostic biomarkers for acute pancreatitis.
    Liu P, Xia L, Zhang WL, Ke HJ, Su T, Deng LB, Chen YX, Lv NH.
    Pancreatology; 2014 Feb 28; 14(3):159-66. PubMed ID: 24854610
    [Abstract] [Full Text] [Related]

  • 28. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
    Zeng XL, Zhang SY, Zheng JF, Yuan H, Wang Y.
    Chin Med J (Engl); 2013 Dec 28; 126(23):4510-6. PubMed ID: 24286416
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H.
    Carcinogenesis; 2012 Apr 28; 33(4):828-34. PubMed ID: 22298638
    [Abstract] [Full Text] [Related]

  • 32. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ.
    Gut; 2009 Oct 28; 58(10):1375-81. PubMed ID: 19201770
    [Abstract] [Full Text] [Related]

  • 33. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.
    Xie L, Wu M, Lin H, Liu C, Yang H, Zhan J, Sun S.
    Mol Biosyst; 2014 May 28; 10(5):1072-81. PubMed ID: 24556821
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis.
    Løvendorf MB, Zibert JR, Gyldenløve M, Røpke MA, Skov L.
    J Dermatol Sci; 2014 Aug 28; 75(2):133-9. PubMed ID: 24909097
    [Abstract] [Full Text] [Related]

  • 35. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
    Yu Y, Zuo J, Tan Q, Zar Thin K, Li P, Zhu M, Yu M, Fu Z, Liang C, Tu J.
    Cancer Biomark; 2017 Aug 28; 18(3):319-327. PubMed ID: 28106539
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
    Iwamoto H, Kanda Y, Sejima T, Osaki M, Okada F, Takenaka A.
    Int J Oncol; 2014 Jan 28; 44(1):53-8. PubMed ID: 24212760
    [Abstract] [Full Text] [Related]

  • 38. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K.
    Cancer Res; 2010 Dec 01; 70(23):9798-807. PubMed ID: 21098710
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.